help button home button Endocrine Society Molecular Endocrinology ENDO 08 Sessions Library
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH

This version published online on July 21, 2005
Molecular Endocrinology, doi:10.1210/me.2005-0111
Molecular Endocrinology Vol. 0, No. 2005 200501111-
doi:10.1210/me.2005-0111
Copyright © 2005 by the Endocrine Society.
This Article
Right arrow Author Manuscript (PDF)
Right arrow All Versions of this Article:
19/12/2901    most recent
Author Manuscript (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow NURSA Molecule Pages Link
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Fan, M.
Right arrow Articles by Nephew, K. P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Fan, M.
Right arrow Articles by Nephew, K. P.
Right arrowPubmed/NCBI databases
*Gene*GEO Profiles
*HomoloGene*UniGene
*Compound via MeSH
*Substance via MeSH

Submitted on March 4, 2005
Accepted on July 14, 2005

CHIP (Carboxyl Terminus of Hsc70-Interacting Protein) Promotes Basal and Geldanamycin-Induced Degradation of Estrogen Receptor-alpha

Meiyun Fan, Annie Park, and Kenneth P. Nephew*

Medical Sciences, Indiana University School of Medicine, Bloomington, IN 47405, Indiana University Cancer Center, Department of Cellular and Integrative Physiology, Indiana University School of Medicine, Indianapolis, IN 46202

* To whom correspondence should be addressed. E-mail: knephew{at}indiana.edu.

In estrogen target cells, estrogen receptor-alpha (ER{alpha}) protein levels are strictly regulated. Although receptor turnover is a continuous process, dynamic fluctuations in receptor levels, mediated primarily by the ubiquitin-proteasome pathway, occur in response to changing cellular conditions. In the absence of ligand, ER{alpha} is sequestered within a stable chaperone protein complex consisting of heat shock protein 90 (Hsp90) and co-chaperones. However, the molecular mechanism(s) regulating ER{alpha} stability and turnover remain undefined. One potential mechanism involves CHIP, the carboxyl terminus of Hsc70-interacting protein, previously shown to target Hsp90 interacting proteins for ubiquitination and proteasomal degradation. In the present study, a role for CHIP in ER{alpha} protein degradation was investigated. In ER-negative HeLa cells transfected with ER{alpha} and CHIP, ER{alpha} proteasomal degradation increased, while ER{alpha}-mediated gene transcription decreased. In contrast, CHIP depletion by siRNA resulted in increased ER{alpha} accumulation and reporter gene transactivation. Transfection of mutant CHIP constructs demonstrated that both the U-box (containing ubiquitin ligase activity) and the tetratricopeptide repeat (TPR, essential for chaperone binding) domains within CHIP are required for CHIP-mediated ER{alpha} down-regulation. In addition, coimmunoprecipitation assays demonstrated that ER{alpha} and CHIP associate through the CHIP TPR domain. In ER{alpha}-positive breast cancer MCF7 cells, CHIP overexpression resulted in decreased levels of endogenous ER{alpha} protein and attenuation of ER{alpha}-mediated gene expression. Furthermore, the ER{alpha}-CHIP interaction was stimulated by the Hsp90 inhibitor geldanamycin (GA), resulting in enhanced ER{alpha} degradation; this GA effect was further augmented by CHIP overexpression, but was abolished by CHIP depletion. Finally, ER{alpha} dissociation from CHIP by various ER{alpha} ligands, including E2, OHT, and ICI, interrupted CHIP-mediated ER{alpha} degradation. These results demonstrate a role for CHIP in both basal and GA-induced ER{alpha} degradation. Furthermore, based on our observations that CHIP promotes ER{alpha} degradation and attenuates receptor-mediated gene transcription, we suggest that CHIP, by modulating ER{alpha} stability, contributes to the regulation of functional receptor levels, and thus hormone responsiveness, in estrogen target cells.


Key words: estrogen receptor • CHIP • geldanamycin • ubiquitin • Hsp90

NURSA Molecule Pages Link:

Nuclear Receptors:   ERα
Ligands:   17β-Estradiol  |  4-Hydroxytamoxifen



This article has been cited by other articles:


Home page
Mol. Endocrinol.Home page
N. B. Berry, M. Fan, and K. P. Nephew
Estrogen Receptor-{alpha} Hinge-Region Lysines 302 and 303 Regulate Receptor Degradation by the Proteasome
Mol. Endocrinol., July 1, 2008; 22(7): 1535 - 1551.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
M. K. Glassberg, S. J. Elliot, J. Fritz, P. Catanuto, M. Potier, R. Donahue, W. Stetler-Stevenson, and M. Karl
Activation of the Estrogen Receptor Contributes to the Progression of Pulmonary Lymphangioleiomyomatosis via Matrix Metalloproteinase-Induced Cell Invasiveness
J. Clin. Endocrinol. Metab., May 1, 2008; 93(5): 1625 - 1633.
[Abstract] [Full Text] [PDF]


Home page
Mol. Endocrinol.Home page
N. Picard, C. Charbonneau, M. Sanchez, A. Licznar, M. Busson, G. Lazennec, and A. Tremblay
Phosphorylation of Activation Function-1 Regulates Proteasome-Dependent Nuclear Mobility and E6-Associated Protein Ubiquitin Ligase Recruitment to the Estrogen Receptor {beta}
Mol. Endocrinol., February 1, 2008; 22(2): 317 - 330.
[Abstract] [Full Text] [PDF]


Home page
Eur J EndocrinolHome page
L. A Naves, A. F Daly, J.-F. Vanbellinghen, L. A Casulari, C. Spilioti, A. V Magalhaes, M. F Azevedo, L. A Giacomini, P. P Nascimento, R. O Nunes, et al.
Variable pathological and clinical features of a large Brazilian family harboring a mutation in the aryl hydrocarbon receptor-interacting protein gene
Eur. J. Endocrinol., October 1, 2007; 157(4): 383 - 391.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
L. Zhang, K. P. Nephew, and P. J. Gallagher
Regulation of Death-associated Protein Kinase: STABILIZATION BY HSP90 HETEROCOMPLEXES
J. Biol. Chem., April 20, 2007; 282(16): 11795 - 11804.
[Abstract] [Full Text] [PDF]


Home page
Nucleic Acids ResHome page
J. Yan, Y.-S. Kim, X.-P. Yang, M. Albers, M. Koegl, and A. M. Jetten
Ubiquitin-interaction motifs of RAP80 are critical in its regulation of estrogen receptor {alpha}
Nucleic Acids Res., March 12, 2007; 35(5): 1673 - 1686.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. Biol.Home page
Y. Tateishi, R. Sonoo, Y.-i. Sekiya, N. Sunahara, M. Kawano, M. Wayama, R. Hirota, Y.-i. Kawabe, A. Murayama, S. Kato, et al.
Turning Off Estrogen Receptor {beta}-Mediated Transcription Requires Estrogen-Dependent Receptor Proteolysis
Mol. Cell. Biol., November 1, 2006; 26(21): 7966 - 7976.
[Abstract] [Full Text] [PDF]


Home page
Mol Cancer ResHome page
C. Chen, A. K. Seth, and A. E. Aplin
Genetic and Expression Aberrations of E3 Ubiquitin Ligases in Human Breast Cancer
Mol. Cancer Res., October 1, 2006; 4(10): 695 - 707.
[Abstract] [Full Text] [PDF]


Home page
Mol. Endocrinol.Home page
E. T. Alarid
Lives and Times of Nuclear Receptors
Mol. Endocrinol., September 1, 2006; 20(9): 1972 - 1981.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
S. Germano, D. Barberis, M. M. Santoro, L. Penengo, A. Citri, Y. Yarden, and G. Gaudino
Geldanamycins Trigger a Novel Ron Degradative Pathway, Hampering Oncogenic Signaling
J. Biol. Chem., August 4, 2006; 281(31): 21710 - 21719.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
X. Long and K. P. Nephew
Fulvestrant (ICI 182,780)-dependent Interacting Proteins Mediate Immobilization and Degradation of Estrogen Receptor-{alpha}
J. Biol. Chem., April 7, 2006; 281(14): 9607 - 9615.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 2005 by The Endocrine Society